DexCom (DXCM) Competitors

DexCom (NASDAQ:DXCM) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Is DXCM or MDT more profitable?

DexCom has a net margin of 14.29% compared to Medtronic's net margin of 12.83%. DexCom's return on equity of 30.14% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	14.29%	30.14%	10.11%
Medtronic	12.83%	14.07%	7.70%

Which has more risk and volatility, DXCM or MDT?

DexCom has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Do insiders & institutionals believe in DXCM or MDT?

97.8% of DexCom shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Comparatively, 0.2% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts rate DXCM or MDT?

DexCom presently has a consensus price target of $98.11, suggesting a potential upside of 13.20%. Medtronic has a consensus price target of $96.14, suggesting a potential upside of 11.17%. Given DexCom's stronger consensus rating and higher probable upside, analysts plainly believe DexCom is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	3 Strong Buy rating(s)	2.95
Medtronic	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.44

Which has preferable valuation and earnings, DXCM or MDT?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.15B	8.19	$576.20M	$1.34	64.68
Medtronic	$33.20B	3.34	$3.68B	$3.29	26.29

Does the MarketBeat Community favor DXCM or MDT?

Medtronic received 604 more outperform votes than DexCom when rated by MarketBeat users. Likewise, 75.42% of users gave Medtronic an outperform vote while only 71.79% of users gave DexCom an outperform vote.

Company	Underperform	Outperform
DexCom	Outperform Votes 985 71.79%	Underperform Votes 387 28.21%
Medtronic	Outperform Votes 1589 75.42%	Underperform Votes 518 24.58%

Does the media refer more to DXCM or MDT?

In the previous week, Medtronic had 16 more articles in the media than DexCom. MarketBeat recorded 45 mentions for Medtronic and 29 mentions for DexCom. DexCom's average media sentiment score of 1.44 beat Medtronic's score of 1.27 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	25 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	35 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

DexCom beats Medtronic on 13 of the 19 factors compared between the two stocks.